A Multi Center, Prospective, Observational, Open-label, Pharmacokinetic Study of Tacrolimus in Heart and Lung Transplantation Patients during the First Days after Transplantation.

Trial Profile

A Multi Center, Prospective, Observational, Open-label, Pharmacokinetic Study of Tacrolimus in Heart and Lung Transplantation Patients during the First Days after Transplantation.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 22 Oct 2015

At a glance

  • Drugs Tacrolimus (Primary)
  • Indications Heart-lung transplant rejection
  • Focus Pharmacokinetics
  • Acronyms SPARTACUS
  • Most Recent Events

    • 15 Oct 2015 Status changed from planning to active, no longer recruiting, according to Netherlands Trial Register record.
    • 15 Apr 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top